RETRACTED ARTICLE: Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-08-27

AUTHORS

Joachim Boldt, Christian Brosch, Stefan Suttner, Sven N. Piper, Andreas Lehmann, Christiane Werling

ABSTRACT

Objective. Elderly patients appear prone to develop overwhelming post-bypass inflammation and organ dysfunction. We assessed the effect of prophylactic administration of the phosphodiesterase III inhibitor enoximone on inflammation and organ function.Design. Prospective, blinded, randomized, placebo-controlled study.Setting. Clinical investigations on a surgical intensive care unit.Patients. 40 consecutive patients aged over 80 years undergoing first-time coronary artery bypass grafting.Interventions. Enoximone was given to 20 patients after induction of anesthesia (initial bolus 0.5 mg/kg) followed by a continuous infusion of 2.5 µg/kg per minute until the 2nd postoperative day. Control patients (n=20) received saline solution.Measurements and results. Interleukins 6, 8, and 10 and soluble adhesion molecules were measured. Liver function was assessed by the monoethylglycine-xylidide test and by measuring α-glutathione S-transferase plasma levels; splanchnic perfusion by continuous gastric tonometry; renal function by measuring creatinine and α1-microglobulin. Interleukins increased significantly more in controls than in the enoximone-pretreated patients. Soluble adhesion molecules were significantly more increased in controls. Liver function was more altered in controls than in the enoximone-pretreated patients. α1-Microglobulin increased significantly more in controls than in the enoximone group, indicating less tubular damage in the verum group.Conclusions. Prophylactic use of enoximone in cardiac surgery patients aged over 80 years resulted in less post-bypass inflammation and improvement in markers of organ function than in the placebo group. The exact mechanisms by which enoximone exerts its beneficial effects in these patients remains to be elucidated. More... »

PAGES

1462-1469

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00134-002-1435-y

DOI

http://dx.doi.org/10.1007/s00134-002-1435-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1040146009

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12373472


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "3',5'-Cyclic-AMP Phosphodiesterases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiopulmonary Bypass", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclic Nucleotide Phosphodiesterases, Type 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enoximone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Germany", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphodiesterase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebos", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boldt", 
        "givenName": "Joachim", 
        "id": "sg:person.01230376335.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230376335.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brosch", 
        "givenName": "Christian", 
        "id": "sg:person.01216712161.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216712161.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suttner", 
        "givenName": "Stefan", 
        "id": "sg:person.01306263750.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306263750.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piper", 
        "givenName": "Sven N.", 
        "id": "sg:person.013112343302.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013112343302.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehmann", 
        "givenName": "Andreas", 
        "id": "sg:person.01265025361.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265025361.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinic of Cardiac Surgery, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Clinic of Cardiac Surgery, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Werling", 
        "givenName": "Christiane", 
        "id": "sg:person.01252302321.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252302321.35"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00002512-199202050-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006760122", 
          "https://doi.org/10.2165/00002512-199202050-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01704701", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045213454", 
          "https://doi.org/10.1007/bf01704701"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002-08-27", 
    "datePublishedReg": "2002-08-27", 
    "description": "Objective. Elderly patients appear prone to develop overwhelming post-bypass inflammation and organ dysfunction. We assessed the effect of prophylactic administration of the phosphodiesterase III inhibitor enoximone on inflammation and organ function.Design. Prospective, blinded, randomized, placebo-controlled study.Setting. Clinical investigations on a surgical intensive care unit.Patients. 40 consecutive patients aged over 80\u00a0years undergoing first-time coronary artery bypass grafting.Interventions. Enoximone was given to 20 patients after induction of anesthesia (initial bolus 0.5\u00a0mg/kg) followed by a continuous infusion of 2.5\u00a0\u00b5g/kg per minute until the 2nd postoperative day. Control patients (n=20) received saline solution.Measurements and results. Interleukins 6, 8, and 10 and soluble adhesion molecules were measured. Liver function was assessed by the monoethylglycine-xylidide test and by measuring \u03b1-glutathione S-transferase plasma levels; splanchnic perfusion by continuous gastric tonometry; renal function by measuring creatinine and \u03b11-microglobulin. Interleukins increased significantly more in controls than in the enoximone-pretreated patients. Soluble adhesion molecules were significantly more increased in controls. Liver function was more altered in controls than in the enoximone-pretreated patients. \u03b11-Microglobulin increased significantly more in controls than in the enoximone group, indicating less tubular damage in the verum group.Conclusions. Prophylactic use of enoximone in cardiac surgery patients aged over 80\u00a0years resulted in less post-bypass inflammation and improvement in markers of organ function than in the placebo group. The exact mechanisms by which enoximone exerts its beneficial effects in these patients remains to be elucidated.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00134-002-1435-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313639", 
        "issn": [
          "0342-4642", 
          "1432-1238"
        ], 
        "name": "Intensive Care Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "cardiac surgery patients", 
      "soluble adhesion molecules", 
      "organ function", 
      "surgery patients", 
      "inhibitor enoximone", 
      "prophylactic use", 
      "liver function", 
      "first-time coronary artery bypass", 
      "elderly cardiac surgery patients", 
      "placebo-controlled study", 
      "surgical intensive care unit", 
      "transferase plasma levels", 
      "less tubular damage", 
      "coronary artery bypass", 
      "induction of anesthesia", 
      "intensive care unit", 
      "adhesion molecules", 
      "enoximone group", 
      "placebo group", 
      "prophylactic administration", 
      "artery bypass", 
      "elderly patients", 
      "postoperative day", 
      "renal function", 
      "tubular damage", 
      "verum group", 
      "organ dysfunction", 
      "consecutive patients", 
      "control patients", 
      "splanchnic perfusion", 
      "care unit", 
      "continuous infusion", 
      "gastric tonometry", 
      "plasma levels", 
      "interleukin 6", 
      "clinical investigation", 
      "patients", 
      "enoximone", 
      "inflammation", 
      "beneficial effects", 
      "exact mechanism", 
      "saline solution", 
      "\u03b11-microglobulin", 
      "glutathione S", 
      "markers", 
      "group", 
      "creatinine", 
      "anesthesia", 
      "interleukin", 
      "tonometry", 
      "hemodynamics", 
      "dysfunction", 
      "infusion", 
      "bypass", 
      "control", 
      "years", 
      "perfusion", 
      "administration", 
      "effect", 
      "days", 
      "minutes", 
      "induction", 
      "function", 
      "use", 
      "damage", 
      "levels", 
      "study", 
      "test", 
      "improvement", 
      "mechanism", 
      "molecules", 
      "units", 
      "investigation", 
      "results", 
      "measurements", 
      "solution", 
      "overwhelming post-bypass inflammation", 
      "post-bypass inflammation", 
      "phosphodiesterase III inhibitor enoximone", 
      "III inhibitor enoximone", 
      "monoethylglycine-xylidide test", 
      "continuous gastric tonometry", 
      "enoximone-pretreated patients", 
      "less post-bypass inflammation", 
      "phospodiesterase III inhibitor enoximone"
    ], 
    "name": "RETRACTED ARTICLE: Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function", 
    "pagination": "1462-1469", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1040146009"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00134-002-1435-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12373472"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00134-002-1435-y", 
      "https://app.dimensions.ai/details/publication/pub.1040146009"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_360.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00134-002-1435-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00134-002-1435-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00134-002-1435-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00134-002-1435-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00134-002-1435-y'


 

This table displays all metadata directly associated to this object as RDF triples.

256 TRIPLES      22 PREDICATES      129 URIs      119 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00134-002-1435-y schema:about N083210cce62c4b2c9d4984a24554bfb9
2 N14c96a7d3d9044a89e2549b6e6390337
3 N2dbd8cb0fcb84081b7e554cc681794f4
4 N3c3a42d1f5bd416cb17ed89cac1bc67e
5 N4eaaba59db894b1dacde102a8ce04a52
6 N649aec0d461d4e74926dd224ae186eea
7 N676e57105dbd452abe8e25f8a35830b1
8 N6a67bfe3623a4299bb27a44909f0a5ce
9 N83ee902a03d248498f70c6608ae63e53
10 N8e6c61f19ffc4f538bc401ecf75ef609
11 Na0b019b63f6e423591cd7c0acbb83edc
12 Na28dba0b57fa46a2b2b5cee6fd39c513
13 Nc2886c28769e43e0914b9d29495253bc
14 Ndd5c29e5355747b492792c822cb32a61
15 Nf9906ada85f74a5fbd835a0ab92576a6
16 Nfb52d031ce7d45068071faa08a9872d8
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N17dab4fc025440849623499e17be0df5
20 schema:citation sg:pub.10.1007/bf01704701
21 sg:pub.10.2165/00002512-199202050-00006
22 schema:datePublished 2002-08-27
23 schema:datePublishedReg 2002-08-27
24 schema:description Objective. Elderly patients appear prone to develop overwhelming post-bypass inflammation and organ dysfunction. We assessed the effect of prophylactic administration of the phosphodiesterase III inhibitor enoximone on inflammation and organ function.Design. Prospective, blinded, randomized, placebo-controlled study.Setting. Clinical investigations on a surgical intensive care unit.Patients. 40 consecutive patients aged over 80 years undergoing first-time coronary artery bypass grafting.Interventions. Enoximone was given to 20 patients after induction of anesthesia (initial bolus 0.5 mg/kg) followed by a continuous infusion of 2.5 µg/kg per minute until the 2nd postoperative day. Control patients (n=20) received saline solution.Measurements and results. Interleukins 6, 8, and 10 and soluble adhesion molecules were measured. Liver function was assessed by the monoethylglycine-xylidide test and by measuring α-glutathione S-transferase plasma levels; splanchnic perfusion by continuous gastric tonometry; renal function by measuring creatinine and α1-microglobulin. Interleukins increased significantly more in controls than in the enoximone-pretreated patients. Soluble adhesion molecules were significantly more increased in controls. Liver function was more altered in controls than in the enoximone-pretreated patients. α1-Microglobulin increased significantly more in controls than in the enoximone group, indicating less tubular damage in the verum group.Conclusions. Prophylactic use of enoximone in cardiac surgery patients aged over 80 years resulted in less post-bypass inflammation and improvement in markers of organ function than in the placebo group. The exact mechanisms by which enoximone exerts its beneficial effects in these patients remains to be elucidated.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree false
28 schema:isPartOf N9c306fe21d784d00bc8deaee053c757d
29 Nf8bf62ff4cb34797b77853f66bc84017
30 sg:journal.1313639
31 schema:keywords III inhibitor enoximone
32 adhesion molecules
33 administration
34 anesthesia
35 artery bypass
36 beneficial effects
37 bypass
38 cardiac surgery patients
39 care unit
40 clinical investigation
41 consecutive patients
42 continuous gastric tonometry
43 continuous infusion
44 control
45 control patients
46 coronary artery bypass
47 creatinine
48 damage
49 days
50 dysfunction
51 effect
52 elderly cardiac surgery patients
53 elderly patients
54 enoximone
55 enoximone group
56 enoximone-pretreated patients
57 exact mechanism
58 first-time coronary artery bypass
59 function
60 gastric tonometry
61 glutathione S
62 group
63 hemodynamics
64 improvement
65 induction
66 induction of anesthesia
67 inflammation
68 infusion
69 inhibitor enoximone
70 intensive care unit
71 interleukin
72 interleukin 6
73 investigation
74 less post-bypass inflammation
75 less tubular damage
76 levels
77 liver function
78 markers
79 measurements
80 mechanism
81 minutes
82 molecules
83 monoethylglycine-xylidide test
84 organ dysfunction
85 organ function
86 overwhelming post-bypass inflammation
87 patients
88 perfusion
89 phosphodiesterase III inhibitor enoximone
90 phospodiesterase III inhibitor enoximone
91 placebo group
92 placebo-controlled study
93 plasma levels
94 post-bypass inflammation
95 postoperative day
96 prophylactic administration
97 prophylactic use
98 renal function
99 results
100 saline solution
101 soluble adhesion molecules
102 solution
103 splanchnic perfusion
104 study
105 surgery patients
106 surgical intensive care unit
107 test
108 tonometry
109 transferase plasma levels
110 tubular damage
111 units
112 use
113 verum group
114 years
115 α1-microglobulin
116 schema:name RETRACTED ARTICLE: Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function
117 schema:pagination 1462-1469
118 schema:productId N0e5ca66eea5247a89f7279a0c673adaf
119 N7f34876519124ed1872c6743cfb3e493
120 Nfc477173f481427186e457b485accf3b
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040146009
122 https://doi.org/10.1007/s00134-002-1435-y
123 schema:sdDatePublished 2022-01-01T18:12
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher Na5455940621f4a0abff89ab580d65e15
126 schema:url https://doi.org/10.1007/s00134-002-1435-y
127 sgo:license sg:explorer/license/
128 sgo:sdDataset articles
129 rdf:type schema:ScholarlyArticle
130 N083210cce62c4b2c9d4984a24554bfb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 N0e5ca66eea5247a89f7279a0c673adaf schema:name dimensions_id
134 schema:value pub.1040146009
135 rdf:type schema:PropertyValue
136 N14c96a7d3d9044a89e2549b6e6390337 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Inflammation
138 rdf:type schema:DefinedTerm
139 N17dab4fc025440849623499e17be0df5 rdf:first sg:person.01230376335.52
140 rdf:rest Ncb6f7c49940f420abec46a2a1047b63c
141 N2b126345682945a4989accd8042bafe9 rdf:first sg:person.01252302321.35
142 rdf:rest rdf:nil
143 N2dbd8cb0fcb84081b7e554cc681794f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Phosphodiesterase Inhibitors
145 rdf:type schema:DefinedTerm
146 N3c3a42d1f5bd416cb17ed89cac1bc67e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Male
148 rdf:type schema:DefinedTerm
149 N4eaaba59db894b1dacde102a8ce04a52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Cardiopulmonary Bypass
151 rdf:type schema:DefinedTerm
152 N5a8dd6cbcea14b769221a0b953458f87 rdf:first sg:person.013112343302.57
153 rdf:rest N6b47e5c3b0584302a853e475f833245f
154 N649aec0d461d4e74926dd224ae186eea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Cyclic Nucleotide Phosphodiesterases, Type 3
156 rdf:type schema:DefinedTerm
157 N676e57105dbd452abe8e25f8a35830b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Female
159 rdf:type schema:DefinedTerm
160 N6a67bfe3623a4299bb27a44909f0a5ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Aged, 80 and over
162 rdf:type schema:DefinedTerm
163 N6b47e5c3b0584302a853e475f833245f rdf:first sg:person.01265025361.36
164 rdf:rest N2b126345682945a4989accd8042bafe9
165 N7f34876519124ed1872c6743cfb3e493 schema:name pubmed_id
166 schema:value 12373472
167 rdf:type schema:PropertyValue
168 N83ee902a03d248498f70c6608ae63e53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Germany
170 rdf:type schema:DefinedTerm
171 N8e6c61f19ffc4f538bc401ecf75ef609 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Prospective Studies
173 rdf:type schema:DefinedTerm
174 N9c306fe21d784d00bc8deaee053c757d schema:volumeNumber 28
175 rdf:type schema:PublicationVolume
176 Na0b019b63f6e423591cd7c0acbb83edc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Hemodynamics
178 rdf:type schema:DefinedTerm
179 Na28dba0b57fa46a2b2b5cee6fd39c513 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Aged
181 rdf:type schema:DefinedTerm
182 Na5455940621f4a0abff89ab580d65e15 schema:name Springer Nature - SN SciGraph project
183 rdf:type schema:Organization
184 Nc2886c28769e43e0914b9d29495253bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Biomarkers
186 rdf:type schema:DefinedTerm
187 Ncb6f7c49940f420abec46a2a1047b63c rdf:first sg:person.01216712161.26
188 rdf:rest Ne95205e8db504df294502746e23a0ffc
189 Ndd5c29e5355747b492792c822cb32a61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name 3',5'-Cyclic-AMP Phosphodiesterases
191 rdf:type schema:DefinedTerm
192 Ne95205e8db504df294502746e23a0ffc rdf:first sg:person.01306263750.09
193 rdf:rest N5a8dd6cbcea14b769221a0b953458f87
194 Nf8bf62ff4cb34797b77853f66bc84017 schema:issueNumber 10
195 rdf:type schema:PublicationIssue
196 Nf9906ada85f74a5fbd835a0ab92576a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Enoximone
198 rdf:type schema:DefinedTerm
199 Nfb52d031ce7d45068071faa08a9872d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Placebos
201 rdf:type schema:DefinedTerm
202 Nfc477173f481427186e457b485accf3b schema:name doi
203 schema:value 10.1007/s00134-002-1435-y
204 rdf:type schema:PropertyValue
205 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
206 schema:name Medical and Health Sciences
207 rdf:type schema:DefinedTerm
208 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
209 schema:name Clinical Sciences
210 rdf:type schema:DefinedTerm
211 sg:journal.1313639 schema:issn 0342-4642
212 1432-1238
213 schema:name Intensive Care Medicine
214 schema:publisher Springer Nature
215 rdf:type schema:Periodical
216 sg:person.01216712161.26 schema:affiliation grid-institutes:grid.413225.3
217 schema:familyName Brosch
218 schema:givenName Christian
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216712161.26
220 rdf:type schema:Person
221 sg:person.01230376335.52 schema:affiliation grid-institutes:grid.413225.3
222 schema:familyName Boldt
223 schema:givenName Joachim
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230376335.52
225 rdf:type schema:Person
226 sg:person.01252302321.35 schema:affiliation grid-institutes:grid.413225.3
227 schema:familyName Werling
228 schema:givenName Christiane
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252302321.35
230 rdf:type schema:Person
231 sg:person.01265025361.36 schema:affiliation grid-institutes:grid.413225.3
232 schema:familyName Lehmann
233 schema:givenName Andreas
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265025361.36
235 rdf:type schema:Person
236 sg:person.01306263750.09 schema:affiliation grid-institutes:grid.413225.3
237 schema:familyName Suttner
238 schema:givenName Stefan
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306263750.09
240 rdf:type schema:Person
241 sg:person.013112343302.57 schema:affiliation grid-institutes:grid.413225.3
242 schema:familyName Piper
243 schema:givenName Sven N.
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013112343302.57
245 rdf:type schema:Person
246 sg:pub.10.1007/bf01704701 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045213454
247 https://doi.org/10.1007/bf01704701
248 rdf:type schema:CreativeWork
249 sg:pub.10.2165/00002512-199202050-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006760122
250 https://doi.org/10.2165/00002512-199202050-00006
251 rdf:type schema:CreativeWork
252 grid-institutes:grid.413225.3 schema:alternateName Clinic of Cardiac Surgery, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany
253 Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany
254 schema:name Clinic of Cardiac Surgery, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany
255 Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany
256 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...